Eleni Bekiari, MD, MSc, PhD; Thomas Karagiannis, MD, MSc; Apostolos Tsapas, MD, MSc, PhD
Bekiari E, Karagiannis T, Tsapas A. In type 2 diabetes, weekly semaglutide reduced HbA1c and increased weight loss more than weekly exenatide ER. Ann Intern Med. ;168:JC46. doi: 10.7326/ACPJC-2018-168-8-046
Download citation file:
Published: Ann Intern Med. 2018;168(8):JC46.
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use